Filing Details
- Accession Number:
- 0001209191-20-008414
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 17:53:36
- Reporting Period:
- 2020-02-07
- Accepted Time:
- 2020-02-11 17:53:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 462702363 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1757776 | Sabah Oney | C/O Alector, Inc. 131 Oyster Point Blvd, Suite 600 South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-07 | 19,900 | $35.03 | 573,918 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $35.00 to $35.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.